trulicity

Generic: dulaglutide

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name trulicity
Generic Name dulaglutide
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

dulaglutide 3 mg/.5mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-2236
Product ID 0002-2236_1c705277-dd8e-46d0-86b0-2b57f47f5e5c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125469
Listing Expiration 2026-12-31
Marketing Start 2020-09-03

Pharmacologic Class

Established (EPC)
glp-1 receptor agonist [epc]
Mechanism of Action
glucagon-like peptide-1 (glp-1) agonists [moa]
Chemical Structure
glucagon-like peptide 1 [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00022236
Hyphenated Format 0002-2236

Supplemental Identifiers

RxCUI
1551295 1551300 1551304 1551306 2395777 2395779 2395783 2395785
UNII
WTT295HSY5
NUI
N0000178480 M0160181 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name trulicity (source: ndc)
Generic Name dulaglutide (source: ndc)
Application Number BLA125469 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 3 mg/.5mL
source: ndc
Packaging
  • 2 SYRINGE in 1 CARTON (0002-2236-61) / .5 mL in 1 SYRINGE
  • 4 SYRINGE in 1 CARTON (0002-2236-80) / .5 mL in 1 SYRINGE (0002-2236-01)
source: ndc

Packages (2)

0002-2236-61 2 SYRINGE in 1 CARTON (0002-2236-61) / .5 mL in 1 SYRINGE 0002-2236-80 4 SYRINGE in 1 CARTON (0002-2236-80) / .5 mL in 1 SYRINGE (0002-2236-01)

Ingredients (1)

dulaglutide (3 mg/.5mL)

Linked Drug Pages (1)

Trulicity ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "1c705277-dd8e-46d0-86b0-2b57f47f5e5c", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["WTT295HSY5"], "rxcui": ["1551295", "1551300", "1551304", "1551306", "2395777", "2395779", "2395783", "2395785"], "spl_set_id": ["463050bd-2b1c-40f5-b3c3-0a04bb433309"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "2 SYRINGE in 1 CARTON (0002-2236-61)  / .5 mL in 1 SYRINGE", "package_ndc": "0002-2236-61", "marketing_start_date": "20200930"}, {"sample": false, "description": "4 SYRINGE in 1 CARTON (0002-2236-80)  / .5 mL in 1 SYRINGE (0002-2236-01)", "package_ndc": "0002-2236-80", "marketing_start_date": "20200903"}], "brand_name": "Trulicity", "product_id": "0002-2236_1c705277-dd8e-46d0-86b0-2b57f47f5e5c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "0002-2236", "generic_name": "Dulaglutide", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trulicity", "active_ingredients": [{"name": "DULAGLUTIDE", "strength": "3 mg/.5mL"}], "application_number": "BLA125469", "marketing_category": "BLA", "marketing_start_date": "20200903", "listing_expiration_date": "20261231"}